The Baker-Polito Administration and the Massachusetts Life Sciences Center (MLSC) announces a $30.95 million in capital grant funding to support the state’s global leadership in the life sciences sector. Quincy College’s Biotechnology and Good Manufacturing Practice program will receive $725,000.

“With the generous Massachusetts Life Science Consortium Grant, the Quincy College Biotechnology and Compliance program will be able to further the study of biotechnology and good manufacturing practice and implement ongoing positives changes initiated by the Quincy College leadership to make the College not only a wonderful work place but also a modern institution that provides the best possible education for students and workforce training for workers throughout the Commonwealth,” said Quincy College President Michael Bellotti.

MLSC funding will enable Quincy College to continue its leadership in providing comprehensive workforce training and education in bio manufacturing. The college’s bio manufacturing certificate and associate degree programs have been at capacity enrollment consistently for the past seven years.

“Quincy College will develop curriculum to train students in gene therapy techniques and purchase new equipment for training in continuous bioprocessing utilizing the upgraded and new equipment purchased through MLSC funding to enhance the student experience. This new funding will build upon $645,000 in previous MLSC funding to support Quincy College’s biotechnology and GMP (Good Manufacturing Practice) programming,” said Bruce Van Dyke, chairperson of the Quincy College Biotechnology and Good Manufacturing Practice Program.

The MLSC’s Competitive Capital Program invests capital dollars through a competitive process in high potential economic development projects that promise to make a significant contribution to the state’s life sciences ecosystem. Moreover, the competitive program aims to address funding gaps in capital dollars, industry support, and federal funding for educational institutions, incubators, research institutions, and workforce training programs, while also catalyzing private and philanthropic investment to match state investment and preparing the life sciences workforce of the future.

“There is a real need in the industry for both qualified professionals graduating from programs like Quincy College’s Biotechnology and GMP program, and for customized incumbent worker training that we offer in our state-of-the-art biotechnology labs at Quincy College,” Bellotti said. “This specialized and customized training pipeline supports the Commonwealth’s biopharma industry from the ground up. Quincy College is uniquely positioned to support skill development for all levels of professionals working in the Biotech industry.

“Quincy College excels at addressing this real-world need head-on, providing a resource for continuing education as incumbent worker training and critical skill development for those just entering the biotechnology industry, ” Bellotti added.

In total, 11 projects across Massachusetts will receive funding through the MLSC’s Competitive Capital Program to support advances in human health, accelerate innovation in the areas of clinical and translational research, and expand the capacity of life sciences development and job growth across the Commonwealth.

For more information on the Quincy College Biotechnology and Good Manufacturing Practice Program, visit: